| 5224 |
Centers for Disease Control and Prevention |
Html |
en |
Influenza Antivirals Adverse Events |
When considering use of influenza antiviral medications, clinicians must consider many factors such as age, weight, renal function, other medical conditions, indications for use, and potential for interaction with other medication - CDC |
| immunologic response | 0.445833 |
| Limited data | 0.379014 |
| clinical treatment trials | 0.434607 |
| inhaled lactose vehicle | 0.50086 |
| Allergic reactions | 0.37092 |
| inhaled zanamivir | 0.730162 |
| age-related safety concerns | 0.41746 |
| oseltamivir treatment | 0.469136 |
| moderate asthma | 0.371712 |
| oral oseltamivir | 0.916084 |
| medically important conditions | 0.413859 |
| throat infections | 0.369549 |
| facial edema | 0.371908 |
| limited number | 0.369229 |
| influenza antiviral medications | 0.48287 |
| antiviral drug | 0.390228 |
| respiratory disease | 0.38112 |
| Transient neuropsychiatric events | 0.433176 |
| Limited safety data | 0.417744 |
| vomiting | 0.414161 |
| zanamivir treatment | 0.473108 |
| influenza vaccines | 0.382864 |
| pulmonary disease | 0.448269 |
|
| seasonal influenza | 0.379015 |
| phase-I study | 0.373908 |
| placebo recipients | 0.379269 |
| cardiac disease | 0.378322 |
| adverse events | 0.74549 |
| careful attention | 0.417717 |
| nasal signs | 0.372331 |
| uncomplicated influenza | 0.393134 |
| self-reported nausea | 0.396853 |
| nausea | 0.415611 |
| persons | 0.47652 |
| powdered lactose vehicle | 0.445891 |
| Health care professionals | 0.414427 |
| acute influenza | 0.39807 |
| common adverse events | 0.46272 |
| medical conditions | 0.377883 |
| public health responses | 0.421621 |
| study medication | 0.375415 |
| forced expiratory volume | 0.444788 |
| renal function | 0.379065 |
| clinical treatment studies | 0.546088 |
| oseltamivir chemoprophylaxis | 0.468669 |
| respiratory function deterioration | 0.436357 |
|
CLICK HERE |
| 6648 |
Centers for Disease Control and Prevention |
Html |
en |
Benefits of a primary care clinic co-located and integrated in a mental health setting for veterans with serious mental illness. |
Efficacy trials have shown that primary care co-located in the mental health setting improves the receipt of high-quality medical care among people with serious mental illness. |
| coronary artery disease | 0.504052 |
| limited primary care | 0.481817 |
| co-located primary care | 0.503085 |
| mental health | 0.827029 |
| emergency department visits | 0.541213 |
| mental health visit | 0.539401 |
| outpatient mental health | 0.47584 |
| primary care providers | 0.476977 |
| community mental health | 0.46591 |
| CVD risk | 0.511391 |
| successive 6-month periods | 0.535618 |
| primary care program | 0.46802 |
| logistic regression | 0.513661 |
| mental health visits | 0.49094 |
| usual primary care | 0.487058 |
| blood pressure | 0.586953 |
| mental illness | 0.530137 |
| primary care services | 0.490444 |
| body mass index | 0.485676 |
| patients | 0.500101 |
| mental health outpatient | 0.482983 |
| repeated-measures logistic regression | 0.4766 |
| goal attainment | 0.531778 |
| primary care provider | 0.494336 |
| primary care visit | 0.537292 |
|
| VA primary care | 0.476518 |
| quality primary care | 0.467811 |
| observation window | 0.498376 |
| VA service connection | 0.496173 |
| high-quality medical care | 0.488507 |
| observation windows | 0.466 |
| VA Medical Center | 0.550267 |
| mental health setting | 0.566978 |
| mental health providers | 0.501253 |
| primary care visits | 0.653772 |
| single primary care | 0.474573 |
| mental health service | 0.490171 |
| Providence VA Medical | 0.54633 |
| Charlson-Deyo comorbidity index | 0.507082 |
| Rhode Island | 0.472906 |
| primary care access | 0.475973 |
| mental health centers | 0.465908 |
| Mental Illness Primary | 0.482478 |
| Illness Primary Care | 0.491814 |
| medical care | 0.50104 |
| enrollment | 0.542603 |
| goal blood pressure | 0.47754 |
| primary care | 0.968819 |
| primary care clinic | 0.624355 |
|
CLICK HERE |
| 6838 |
Centers for Disease Control and Prevention |
Html |
en |
Meningitis - Parasitic |
Primary amebic meningoencephalitis (PAM) is a very rare form of parasitic meningitis that causes a fatal brain infection. The parasite enters the body through the nose and is caused by the microscopic ameba (a single-celled living organism) Naegleria fowleri. |
| clinical management | 0.540314 |
| eosinophilic meningoencephalitis | 0.602107 |
| eosinophilic meningitis | 0.735379 |
| mental status | 0.54074 |
| Baylisascaris infection | 0.653928 |
| Related Links section | 0.652231 |
| painful feelings | 0.538715 |
| stiff neck | 0.539515 |
| common types | 0.538142 |
| raccoon feces | 0.696383 |
| various ways | 0.683425 |
| neurologic angiostrongyliasis | 0.580328 |
| rare form | 0.568942 |
| undercooked freshwater fish | 0.689379 |
| additional details | 0.552681 |
| Pacific Islands | 0.546783 |
| EM | 0.64473 |
| parasitic meningitis | 0.716835 |
| particularly young children | 0.658573 |
| low-grade fever | 0.54709 |
| infectious parasite eggs | 0.672276 |
| cerebrospinal fluid | 0.593014 |
| undercooked snails | 0.573172 |
| main parasites | 0.783527 |
|
| infectious form | 0.551007 |
| United States | 0.54588 |
| G. spinigerum | 0.743378 |
| noninfectious causes | 0.578423 |
| Gnathostoma spinigerum | 0.627423 |
| A. cantonensis | 0.735043 |
| B. procyonis | 0.74128 |
| Southeast Asia | 0.541521 |
| Various parasites | 0.81608 |
| neural larva migrans | 0.690442 |
| infected people | 0.66441 |
| bacterial meningitis | 0.716061 |
| spinal cord | 0.558014 |
| visit CDC | 0.683958 |
| neurologic form | 0.555253 |
| white blood cell | 0.706322 |
| travel/exposure history | 0.541041 |
| animal waste | 0.544575 |
| symptomatic EM | 0.603293 |
| people | 0.776557 |
| Angiostrongylus cantonensis | 0.629099 |
| healthcare provider | 0.542383 |
| parasites | 0.918803 |
| commonly Baylisascaris | 0.579118 |
|
CLICK HERE |
| 9971 |
Centers for Disease Control and Prevention |
Html |
en |
Indoor Safety for Winter Weather |
Taking preventive action is your best defense against having to deal with extreme cold-weather conditions. By preparing your home and car in advance for winter emergencies, and by observing safety precautions during times of extremely cold weather, you can reduce the risk of weather-related health problems. |
| temperatures | 0.458116 |
| winter storms | 0.788413 |
| stages | 0.371516 |
|
| challenge | 0.397336 |
| winter storm | 0.722421 |
|
CLICK HERE |
| 10643 |
Centers for Disease Control and Prevention |
Html |
en |
Creative Briefs'Resources' Communicating in the First Hours |
The CERC training program educates people on the principles and application of crisis and emergency risk communication when responding to a public health emergency. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 11144 |
Centers for Disease Control and Prevention |
Html |
en |
B Virus | Home | Herpes B | CDC |
CDC Herpes B virus site home page |
| infection | 0.635366 |
| crab-eating | 0.226819 |
| pig-tailed macaques | 0.615171 |
| following criteria | 0.336303 |
| death | 0.224701 |
| laboratory workers | 0.340958 |
| scratches | 0.236268 |
| fever | 0.225281 |
| long-tailed macaques | 0.629838 |
| cynomolgus monkeys | 0.412854 |
| mild symptoms | 0.353877 |
| virus | 0.918673 |
| mucosal contact | 0.349257 |
| veterinarians | 0.226109 |
| Risks | 0.224596 |
| rhesus macaques | 0.638193 |
| patient | 0.22467 |
| Old World macaques | 0.688904 |
| close contact | 0.334404 |
| monkey B virus | 0.599691 |
|
| Treatment sections | 0.342452 |
| macaques | 0.745557 |
| monkey cell cultures | 0.462799 |
| antiviral therapy | 0.34999 |
| herpes virus | 0.612453 |
| macaque monkeys | 0.592831 |
| greatest risk | 0.340917 |
| body fluids | 0.345807 |
| animal bites | 0.343507 |
| adulthood | 0.236447 |
| natural host | 0.353772 |
| exposure | 0.225235 |
| severe brain damage | 0.463509 |
| Initial symptoms | 0.335928 |
| active viral shedding | 0.4841 |
| headache | 0.228397 |
| time | 0.22576 |
| vesicular skin lesions | 0.473011 |
| humans | 0.328614 |
|
CLICK HERE |
| 11475 |
Centers for Disease Control and Prevention |
Html |
en |
ELISA Software for Bioassays | Manual | Introduction |
Introduction to the ELISA for Windows user's manual. |
| Installation Qualification Protocol | 0.451368 |
| Analysis Software page | 0.459127 |
| standards data file | 0.380601 |
| Windows text editor | 0.370902 |
| dialog windows | 0.352771 |
| program | 0.55415 |
| program module option | 0.386462 |
| Windows operating systems | 0.383114 |
| left mouse button | 0.428142 |
| options | 0.35838 |
| parameter estimation | 0.462199 |
| ELISA Windows icon | 0.547842 |
| .DAT files | 0.37259 |
| ELISA plate format | 0.505874 |
| module | 0.409869 |
| documentation | 0.350193 |
| program execution | 0.337738 |
| public domain programs | 0.345004 |
| users | 0.445344 |
| parameter estimation module | 0.372009 |
| word processing program | 0.360536 |
| coefficient files | 0.346019 |
| different program modules | 0.360625 |
| normal data sets | 0.35679 |
| files | 0.475612 |
|
| elisa reader | 0.668163 |
| Raw data files | 0.388142 |
| ELISA | 0.93257 |
| different data file | 0.372637 |
| 96-well ELISA plate | 0.565264 |
| option buttons | 0.374841 |
| standard ASCII text | 0.339836 |
| standard curve estimation | 0.345077 |
| disk subdirectory structures | 0.341216 |
| file | 0.443389 |
| parameter estimation section | 0.341153 |
| comment lines | 0.472643 |
| protocol guides users | 0.439938 |
| concentration calculation module | 0.359477 |
| text boxes | 0.379111 |
| standard curve | 0.43158 |
| data processing | 0.476705 |
| Operational Qualification Protocol | 0.42401 |
| standard curve line | 0.34202 |
| Qualification Protocol guides | 0.337444 |
| windows | 0.744641 |
| spline fit | 0.388909 |
| ASCII text files | 0.352274 |
| unweighted least squares | 0.384982 |
|
CLICK HERE |
| 13916 |
Centers for Disease Control and Prevention |
Html |
en |
Sealants - FAQs - Publications - Division of Oral Health |
null |
| No. Fluorides | 0.353347 |
| food particles | 0.475763 |
| tooth structure | 0.487592 |
| grooves | 0.36526 |
| dental fillings | 0.335757 |
| smiles | 0.227821 |
| tongue | 0.225961 |
| dental care | 0.425351 |
| sealants | 0.913674 |
| teens | 0.225214 |
| pits | 0.226634 |
| special gel | 0.342844 |
| community water supplies | 0.43519 |
| safe plastic coating | 0.424358 |
| surfaces | 0.254313 |
| children | 0.228561 |
| Decay damages teeth | 0.51794 |
| wise food choices | 0.420258 |
| preventive dental program | 0.42785 |
| Teeth tip sheet | 0.459127 |
| protective shield | 0.338641 |
| Dental sealants | 0.562326 |
|
| preventive dental care | 0.424038 |
| germs | 0.275033 |
| Permanent molars | 0.403488 |
| process | 0.227881 |
| tooth decay | 0.757295 |
| chance | 0.225533 |
| surface | 0.226 |
| regular dental appointment | 0.429632 |
| drilling | 0.252091 |
| regular dental care | 0.415526 |
| dentist | 0.22886 |
| child talks | 0.325319 |
| mouth rinse | 0.347418 |
| toothpaste | 0.230188 |
| discomfort | 0.229298 |
| light | 0.225265 |
| different way | 0.329101 |
| plastic coatings | 0.347603 |
| time | 0.244656 |
| dental hygienist | 0.344659 |
| Link | 0.225096 |
|
CLICK HERE |
| 15798 |
Centers for Disease Control and Prevention |
Html |
en |
Infographic: The Power of Preparedness | Partnerships | PHPR |
Office of Public Health Preparedness and Response. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 16077 |
Centers for Disease Control and Prevention |
Html |
en |
Insecticide Resistance |
Information on Zika virus. Provided by the U.S. Centers for Disease Control and Prevention. |
| potential causes | 0.482402 |
| insecticide resistance testing | 0.7537 |
| threshold times | 0.65803 |
| vector management programs | 0.563126 |
| equine encephalitis virus | 0.552245 |
| outdoor sprays | 0.495816 |
| additional species | 0.478984 |
| control operations | 0.485986 |
| diagnostic dose | 0.483167 |
| resistance management component | 0.646523 |
| insecticide resistance | 0.929771 |
| CDC bottle | 0.531826 |
| control strategies | 0.484932 |
| program planning | 0.483166 |
| arboviruses | 0.42044 |
| vector populations | 0.505836 |
| certain class | 0.483915 |
| Ae. albopictus | 0.485921 |
| CDC entomology laboratory | 0.556173 |
| various susceptible colonies | 0.553784 |
| Aedes aegypti | 0.489299 |
| Culex species mosquitoes | 0.644611 |
| cut-off times | 0.482208 |
| United States | 0.477048 |
| Provide baseline data | 0.556355 |
|
| Mosquito Control | 0.509891 |
| timely management | 0.485038 |
| insecticide product | 0.633034 |
| bottle bioassay threshold | 0.623992 |
| diagnostic doses | 0.539859 |
| chikungunya viruses | 0.503009 |
| bioassays | 0.416323 |
| important vectors | 0.482311 |
| control failures | 0.484083 |
| St. Louis | 0.477327 |
| insecticides | 0.471396 |
| foggers | 0.424759 |
| vector population | 0.483349 |
| pesticide selection | 0.48473 |
| pre-determined threshold time | 0.587429 |
| annual monitoring | 0.483765 |
| overall reduction | 0.481795 |
| dengue | 0.419959 |
| mortality rate | 0.47602 |
| Florida Coordinating Council | 0.556031 |
| target populations | 0.497908 |
| diagnostic dosages | 0.482312 |
| insecticide active ingredient | 0.68391 |
| West Nile virus | 0.54261 |
|
CLICK HERE |